Pregnant women exposed to common flame retardants may face preterm birth risk

The French drug com­pa­ny Servi­er has been or­dered to pay an­oth­er hefty fine for its role in a scan­dal re­lat­ed to its weight loss drug

As rare dis­ease drug re­search in­creas­es among large phar­ma com­pa­nies, so do their rep­u­ta­tions with rare dis­ease pa­tient groups. The lat­est sur­vey in Pa­tientView’s an­nu­al